0001628280-22-000182.txt : 20220104 0001628280-22-000182.hdr.sgml : 20220104 20220104161704 ACCESSION NUMBER: 0001628280-22-000182 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220104 DATE AS OF CHANGE: 20220104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hagan Joseph P CENTRAL INDEX KEY: 0001465278 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36421 FILM NUMBER: 22506156 MAIL ADDRESS: STREET 1: 3344 N. TORREY PINES COURT, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001600620 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 BUSINESS PHONE: 250-708-4272 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 4 1 wf-form4_164133098196321.xml FORM 4 X0306 4 2022-01-03 0 0001600620 Aurinia Pharmaceuticals Inc. AUPH 0001465278 Hagan Joseph P #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8 BRITISH COLUMBIA, CANADA 1 0 0 0 Common Stock 2022-01-03 4 M 0 40000 5.08 A 43500 D Common Stock 2022-01-03 4 S 0 39366 22.58 D 4134 D Common Stock 2022-01-03 4 S 0 634 23.29 D 3500 D Stock Option (right to buy) 5.08 2022-01-03 4 M 0 40000 0 D 2028-02-08 Common Stock 40000.0 10000 D Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.27 to $23.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date. /s/ Joseph P. Hagan 2022-01-04